3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Breast Neoplasms
4
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Seminoma
1
Prostate Cancer Metastatic
1
Ovarian Neoplasms
1
Neutropenia
1
Lymphoma, B-Cell
1
Hodgkin Disease
1
Endodermal Sinus Tumor
1
Central Nervous System Neoplasms
1
Castrate Resistant Prostate Cancer
1
Interventions
Etoposide
17
Filgrastim
16
Carboplatin
16
Ifosfamide
15
Peripheral Blood Stem Cell Transplantation
14
Cisplatin
14
Paclitaxel
12
Cyclophosphamide
8
Bleomycin
7
Radiotherapy
6
pegfilgrastim
4
Thiotepa
4
etoposide phosphate
3
sargramostim
2
aldesleukin
2
Vinblastine
2
Temozolomide
2
Methylprednisolone
2
Magnetic Resonance Spectroscopy
2
Immunohistochemistry
2
Granisetron
2
Gemcitabine
2
Dexamethasone
2
Busulfan
2
Alemtuzumab
2
tislelizumab
1
sabarubicin
1
milademetan
1
lerisetron
1
ixabepilone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Testicular Germ Cell Tumor
×
Lenograstim
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled